Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-771.33%
↓ 83% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-421.93%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -771.33% | -67.9% |
| 2024 | -459.37% | -152.1% |
| 2023 | -182.21% | +43.7% |
| 2022 | -323.87% | -141.6% |
| 2021 | -134.07% | -4.4% |
| 2020 | -128.45% | +90.7% |
| 2019 | -1376.11% | - |
| 2018 | 0.00% | - |